Celcuity shares fall as launch delay eclipses US approval for breast cancer drug - Reuters
Celcuity shares fall as launch delay eclipses US approval for breast cancer drug Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxNX1pJbjBWT2s0X0RCTFN5dEdyRG93Y0llSE5acllyMlhNek15SENaUjdicjlZanZWUGhlMzktUWdra1ZuVHNyZEx5eXRqUjRreURxaC1icjBKSGR6UnZqdmFoMmdiWnYtd0JoRlU3dTE3UzNmV0ZNZWtUMnJrNmJZU0dtZV9wZTM1cFlfNnZ4RUtvTnFQeWxjUjhzdVozVnkzWTl2RGJPQmRBMUlHRy1vNDNxZnM2bXU5R2V3YTZzdlZYYnJUaHUyUg?oc=5" target="_blank">Celcuity shares fall as launch delay eclipses US approval for breast cancer drug</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Lawsuit against Bristol Myers over delayed cancer drug is revived - Reuters
Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters
August 13, 2026 at 06:00 PMUS FDA approves Bristol Myers' blood cancer treatment - Reuters
US FDA approves Bristol Myers' blood cancer treatment Reuters
August 13, 2026 at 09:33 PMModerna shares double as cancer vaccine data rekindles investor hopes - Reuters
Moderna shares double as cancer vaccine data rekindles investor hopes Reuters
August 19, 2026 at 04:49 PMModerna shares surge as melanoma vaccine with Merck succeeds in large trial - reuters.com
Moderna shares surge as melanoma vaccine with Merck succeeds in large trial reuters.com
August 19, 2026 at 12:17 PMAs Hims prepares for peptides launch, Wall Street cautious on prospects this year - Reuters
As Hims prepares for peptides launch, Wall Street cautious on prospects this year Reuters
August 12, 2026 at 06:34 PMCerebras shares plummet 16% after results fail to impress investors - Reuters
Cerebras shares plummet 16% after results fail to impress investors Reuters
August 12, 2026 at 11:45 PM